<DOC>
	<DOCNO>NCT01099267</DOCNO>
	<brief_summary>Multi-center , survival data collection subject previously enrol study NCT00065156 ( Celgene Protocol CC-5013-MDS-003 ) .</brief_summary>
	<brief_title>Multi-center , Survival Data Collection Subjects Previously Enrolled Celgene Protocol CC-5013-MDS-003</brief_title>
	<detailed_description />
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<criteria>1 . Must enrol Celgene protocol CC5013MDS003 study . 2 . Must understand able give inform consent ( subject decease , proper legal consent ( i.e . next kin , legal representative ) obtain prior collection data ) . 1 . Consent refuse reason current longterm follow complete 2007 ( longterm follow : survival data collection complete obtain safety information CC5013MDS003 discontinue subject May October 2007 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>MDS</keyword>
</DOC>